COMMUNIQUÉS West-GlobeNewswire

-
OSE Immunotherapeutics to Host Conference Call on April 5, 2018 to Discuss Boehringer Ingelheim Global Immuno-Oncology Partnership
05/04/2018 -
PUBLICATION IN ACCORDANCE WITH ARTICLE 14 OF THE BELGIAN LAW OF 2 MAY 2007 REGARDING THE PUBLICATION OF MAJOR SHAREHOLDINGS (THE "TRANSPARENCY LAW")
05/04/2018 -
PUBLICATION IN ACCORDANCE WITH ARTICLE 14 OF THE BELGIAN LAW OF 2 MAY 2007 REGARDING THE PUBLICATION OF MAJOR SHAREHOLDINGS (THE "TRANSPARENCY LAW")
05/04/2018 -
Santhera Announces Successful Completion of First Clinical Trial with Omigapil in Patients with Congenital Muscular Dystrophy
05/04/2018 -
Biocartis Group NV: Biocartis announces publication of its 2017 annual report
05/04/2018 -
Mesa Labs Declares Quarterly Dividend
05/04/2018 -
CORRECTING and REPLACING - Precision Therapeutics Releases Highlights from FY 2017 Business Update Call
05/04/2018 -
Sorrento Therapeutics to Present at H.C. Wainwright Global Lifesciences Conference 04/09/18
04/04/2018 -
Align Technology Extends Invisalign G5 Precision Bite Ramps to Vivera Retainers
04/04/2018 -
Align Technology Introduces Invisalign Clear Aligners for Phase 1 Treatment of Younger Patients With Early Mixed Dentition
04/04/2018 -
Align Technology Expands Invisalign® Product Portfolio With New Options and Greater Flexibility to Treat a Broader Range of Patients
04/04/2018 -
T2 Biosystems Reports Granting of Inducement Awards
04/04/2018 -
Conatus Pharmaceuticals Announces Top-line Results from Phase 2b POLT-HCV-SVR Clinical Trial
04/04/2018 -
Immunovaccine Files Circular for Annual and Special Meeting of Shareholders
04/04/2018 -
Intercept Pharmaceuticals Announces Proposed $120 Million Public Offering and Concurrent $92 Million Private Placement of Common Stock
04/04/2018 -
Paratek’s New Drug Applications for Oral and Intravenous Omadacycline Accepted for Priority Review by FDA
04/04/2018 -
Collegium to Present at the H.C. Wainwright Global Life Sciences Conference
04/04/2018 -
CRISPR Therapeutics Announces the Appointment of Steve Caffé as Head of Regulatory Affairs
04/04/2018 -
Apricus Biosciences Announces Closing of $3.55 Million Public Offering
04/04/2018
Pages